Michael-Jubeli R et al. |
High-temperature gas chromatography-mass spectrometry for skin surface lipids profiling. |
2011 |
J. Lipid Res. |
pmid:20952798
|
Lama-Muñoz A et al. |
New hydrothermal treatment of alperujo enhances the content of bioactive minor components in crude pomace olive oil. |
2011 |
J. Agric. Food Chem. |
pmid:21265536
|
Ellebedy AH et al. |
Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21270336
|
Morel S et al. |
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. |
2011 |
Vaccine |
pmid:21256188
|
Sarpietro MG et al. |
Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers. |
2011 |
Int J Pharm |
pmid:21219999
|
Brasser AJ et al. |
Presence of wax esters and squalene in human saliva. |
2011 |
Arch. Oral Biol. |
pmid:21247555
|
Arguedas A et al. |
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age. |
2011 |
Hum Vaccin |
pmid:21285531
|
Manuel O et al. |
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. |
2011 |
Clin. Infect. Dis. |
pmid:21288852
|
Alghisi F et al. |
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis. |
2011 |
Thorax |
pmid:21228426
|
Decaro N et al. |
Immunogenicity and protective efficacy in dogs of an MF59â„¢-adjuvanted vaccine against recombinant canine/porcine coronavirus. |
2011 |
Vaccine |
pmid:21272607
|
Arias JL et al. |
Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. |
2011 |
ACS Nano |
pmid:21275408
|
Lopez P et al. |
Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults. |
2011 |
J. Infect. Dis. |
pmid:21606530
|
Cen-Pacheco F et al. |
Cytotoxic oxasqualenoids from the red alga Laurencia viridis. |
2011 |
Eur J Med Chem |
pmid:21616566
|
Raouane M et al. |
Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma. |
2011 |
J. Med. Chem. |
pmid:21561161
|
Nowosielski M and Hoffmann M |
Do the substituent effects affect conformational freedom of squalene in hopene biosynthesis? |
2011 |
J Mol Model |
pmid:21562825
|
Hernández-GarcÃa I et al. |
[Adverse events after administration of A/H1N1 vaccine to patients]. |
2011 |
Med Clin (Barc) |
pmid:20199781
|
Fenoglio D et al. |
MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine. |
2011 |
J Prev Med Hyg |
pmid:22010544
|
Precioso AR et al. |
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems. |
2011 |
Vaccine |
pmid:21945258
|
Pariani E et al. |
Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. |
2011 |
Vaccine |
pmid:21974995
|
Andrews NJ et al. |
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. |
2011 |
Vaccine |
pmid:21875635
|
Vesikari T et al. |
Oil-in-water emulsion adjuvant with influenza vaccine in young children. |
2011 |
N. Engl. J. Med. |
pmid:21995388
|
Bernstein DI |
Vaccines for cytomegalovirus. |
2011 |
Infect Disord Drug Targets |
pmid:22309618
|
Fox CB et al. |
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions. |
2011 |
Pharm Dev Technol |
pmid:20550484
|
Niehaus TD et al. |
Identification of unique mechanisms for triterpene biosynthesis in Botryococcus braunii. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21746901
|
Kaya K et al. |
Thraustochytrid Aurantiochytrium sp. 18W-13a accummulates high amounts of squalene. |
2011 |
Biosci. Biotechnol. Biochem. |
pmid:22056449
|
Cheong HJ et al. |
Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. |
2011 |
Clin. Vaccine Immunol. |
pmid:21715575
|
Soto G et al. |
Acetoacetyl-CoA thiolase regulates the mevalonate pathway during abiotic stress adaptation. |
2011 |
J. Exp. Bot. |
pmid:21908473
|
Celia C et al. |
Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. |
2011 |
Expert Opin Drug Deliv |
pmid:22077480
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Puig-Barberà J et al. |
MF59â„¢-adjuvanted seasonal influenza vaccine in young children. |
2011 |
Expert Rev Vaccines |
pmid:22043952
|
Viganò A et al. |
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795458
|
Huijskens E et al. |
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. |
2011 |
Clin. Vaccine Immunol. |
pmid:21795459
|
Pollard AJ and Hill AV |
Antibody repertoire: embracing diversity. |
2011 |
Sci Transl Med |
pmid:21795586
|
Okike IO et al. |
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. |
2011 |
Vaccine |
pmid:21742005
|
Kowert BA and Watson MB |
Diffusion of organic solutes in squalane. |
2011 |
J Phys Chem B |
pmid:21780767
|
Mackay D and Jones PJ |
Evaluation of methods for the determination of cholesterol absorption and synthesis in humans. |
2011 |
Atherosclerosis |
pmid:21763652
|
Jawaid AM et al. |
Shape-controlled colloidal synthesis of rock-salt lead selenide nanocrystals. |
2011 |
ACS Nano |
pmid:21770427
|
Oliaro-Bosso S et al. |
Characterization of the channel constriction allowing the access of the substrate to the active site of yeast oxidosqualene cyclase. |
2011 |
PLoS ONE |
pmid:21811565
|
Bildstein L et al. |
Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes. |
2011 |
Eur J Pharm Biopharm |
pmid:21784150
|
Della Cioppa G et al. |
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. |
2011 |
Vaccine |
pmid:21906647
|
Fox CB et al. |
Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. |
2011 |
Vaccine |
pmid:21906648
|
Zuccotti GV et al. |
Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus. |
2011 |
Diabet. Med. |
pmid:21916971
|
Meyer K et al. |
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection. |
2011 |
PLoS ONE |
pmid:21887300
|
Broeders NE et al. |
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. |
2011 |
Clin J Am Soc Nephrol |
pmid:21921153
|
Achiraman S et al. |
Increased squalene concentrations in the clitoral gland during the estrous cycle in rats: an estrus-indicating scent mark? |
2011 |
Theriogenology |
pmid:21924481
|
Weyermann C et al. |
Initial results on the composition of fingerprints and its evolution as a function of time by GC/MS analysis. |
2011 |
J. Forensic Sci. |
pmid:20707835
|
Wu J et al. |
Superior protection provided by a single dose of MF59-adjuvanted whole inactivated H5N1 influenza vaccine in type 1 diabetic mice. |
2011 |
Arch. Virol. |
pmid:21110049
|
Packwood DM and Phillips LF |
A stochastic, local mode study of neon-liquid surface collision dynamics. |
2011 |
Phys Chem Chem Phys |
pmid:21042647
|
Andrews N et al. |
Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. |
2011 |
J. Infect. Dis. |
pmid:21148494
|
Kajaste-Rudnitski A et al. |
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals. |
2011 |
AIDS |
pmid:21150561
|
Launay O et al. |
Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
2011 |
J. Infect. Dis. |
pmid:21628666
|
Piccialli V et al. |
Isolation of a bis-iodurated tetra-THF as a trace product from the oxidation of squalene with RuOâ‚„ and its double ring expansion to a novel bis-THF-bis-THP compound. |
2011 |
Molecules |
pmid:21709619
|
Iannazzo S |
Pharmacoeconomic evaluation of the MF59--adjuvanted influenza vaccine in the elderly population in Italy. |
2011 |
J Prev Med Hyg |
pmid:21710816
|
Seubert A et al. |
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:21690334
|
Khurana S et al. |
MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. |
2011 |
Sci Transl Med |
pmid:21632986
|
Zhang LW et al. |
Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions. |
2011 |
Int J Nanomedicine |
pmid:21556344
|
Lens M and Podesta Marty MH |
Assessment of the kinetics of the antioxidative capacity of topical antioxidants. |
2011 |
J Drugs Dermatol |
pmid:21369642
|
Cristiani C et al. |
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district. |
2011 |
Vaccine |
pmid:21396903
|
Tabache F et al. |
Acute polyarthritis after influenza A (H1N1) immunization. |
2011 |
Joint Bone Spine |
pmid:21444232
|
Sun Y et al. |
A reproducible in-vivo model of lymphatic malformation in rats. |
2011 |
J. Comp. Pathol. |
pmid:21419420
|
Meier S et al. |
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. |
2011 |
Vaccine |
pmid:21419775
|
Réjiba S et al. |
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer. |
2011 |
Nanomedicine |
pmid:21419876
|
Banzhoff A et al. |
Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations. |
2011 |
Hum Vaccin |
pmid:21422814
|
Parretta E et al. |
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination. |
2011 |
Vaccine |
pmid:21406267
|
Ambike A et al. |
Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane. |
2011 |
Langmuir |
pmid:21413743
|
Gao J et al. |
Laser-induced acoustic desorption/atmospheric pressure chemical ionization mass spectrometry. |
2011 |
J. Am. Soc. Mass Spectrom. |
pmid:21472571
|
Weschler CJ et al. |
Squalene and cholesterol in dust from danish homes and daycare centers. |
2011 |
Environ. Sci. Technol. |
pmid:21476540
|
O'Hagan DT et al. |
MF59 adjuvant: the best insurance against influenza strain diversity. |
2011 |
Expert Rev Vaccines |
pmid:21506643
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children and adolescents with Williams or Cornelia De Lange syndrome. |
2011 |
Hum Vaccin |
pmid:21508673
|
AÄimoviÄ J et al. |
Circadian rhythm of cholesterol synthesis in mouse liver: a statistical analysis of the post-squalene metabolites in wild-type and Crem-knock-out mice. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21531203
|
Siedenburg G and Jendrossek D |
Squalene-hopene cyclases. |
2011 |
Appl. Environ. Microbiol. |
pmid:21531832
|
Tsai TF et al. |
Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. |
2011 |
Scand. J. Infect. Dis. |
pmid:21534891
|
Esposito S et al. |
Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. |
2011 |
Pediatrics |
pmid:21464195
|
Esposito S et al. |
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients. |
2011 |
Nephrol. Dial. Transplant. |
pmid:20974645
|
Montana M et al. |
Safety review: squalene and thimerosal in vaccines. |
2010 Nov-Dec |
Therapie |
pmid:21176760
|
Smentek L and Hess BA |
Compelling computational evidence for the concerted cyclization of the ABC rings of hopene from protonated squalene. |
2010 |
J. Am. Chem. Soc. |
pmid:21080653
|
Fragapane E et al. |
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. |
2010 |
Clin. Vaccine Immunol. |
pmid:20810680
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Khurana S et al. |
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. |
2010 |
Sci Transl Med |
pmid:20371470
|
Ansaldi F et al. |
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. |
2010 |
Vaccine |
pmid:20433807
|
Pili B et al. |
Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study. |
2010 |
Biochim. Biophys. Acta |
pmid:20435013
|
Gylling H et al. |
Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. |
2010 |
J. Lipid Res. |
pmid:20436182
|
Chen G et al. |
Optimization of nitrogen source for enhanced production of squalene from thraustochytrid Aurantiochytrium sp. |
2010 |
N Biotechnol |
pmid:20412873
|
Xiao L et al. |
The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system. |
2010 |
Biomaterials |
pmid:20488530
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Caligiani A et al. |
Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction. |
2010 |
Plant Foods Hum Nutr |
pmid:20607413
|
Zhao RY et al. |
Cloning and characterization of squalene synthase gene from Fusarium fujikuroi (Saw.) Wr. |
2010 |
J. Ind. Microbiol. Biotechnol. |
pmid:20585832
|
Yasuda Y et al. |
Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. |
2010 |
Adv Ther |
pmid:20586002
|
Frey SE et al. |
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
2010 |
Vaccine |
pmid:20619382
|
Tsuchiya M et al. |
Cholesterol biosynthesis pathway intermediates and inhibitors regulate glucose-stimulated insulin secretion and secretory granule formation in pancreatic beta-cells. |
2010 |
Endocrinology |
pmid:20685866
|
Camilloni B et al. |
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. |
2010 |
Vaccine |
pmid:20846530
|
Ihara T |
[Evaluation of alum-adjuvanted whole virus influenza vaccine and future aspects of influenza A (H1N1) 2009 vaccine]. |
2010 |
Uirusu |
pmid:20848866
|
Sere YY et al. |
A Saccharomyces cerevisiae strain unable to store neutral lipids is tolerant to oxidative stress induced by α-synuclein. |
2010 |
Free Radic. Biol. Med. |
pmid:20850523
|
Camera E et al. |
Comprehensive analysis of the major lipid classes in sebum by rapid resolution high-performance liquid chromatography and electrospray mass spectrometry. |
2010 |
J. Lipid Res. |
pmid:20719760
|
Watanabe T et al. |
Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20728352
|
Ray R et al. |
Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. |
2010 |
J. Infect. Dis. |
pmid:20677942
|
Nováková Z et al. |
Effects of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor pravastatin on membrane lipids and membrane associated functions of Methanothermobacter thermautotrophicus. |
2010 |
Folia Microbiol. (Praha) |
pmid:20680571
|
Bate J et al. |
Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. |
2010 |
Clin. Infect. Dis. |
pmid:21067352
|
Madhun AS et al. |
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. |
2010 |
Vaccine |
pmid:21034828
|
Kato S et al. |
Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. |
2010 |
J Nanosci Nanotechnol |
pmid:21137794
|